Kristina M. Broadbelt
Public Communications Contact bei Shire ViroPharma, Inc.
Aktive Positionen von Kristina M. Broadbelt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Public Communications Contact | 17.06.2010 | - |
| General Counsel | - | 03.05.2012 | |
| Corporate Officer/Principal | 17.06.2010 | 31.08.2010 |
Karriereverlauf von Kristina M. Broadbelt
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Public Communications Contact | 1 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
- Börse
- Insiders
- Kristina M. Broadbelt
- Erfahrung
